s6y

Evaxion A/S

Ticker
EVAX
CIK
1828253
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Evaxion Biotech A/S

Ownership 19

  1. 3 Initial statement of beneficial ownership of securities
  2. 3/A Initial statement of beneficial ownership of securities
  3. 3/A Initial statement of beneficial ownership of securities
  4. 3/A Initial statement of beneficial ownership of securities
  5. 3/A Initial statement of beneficial ownership of securities
  6. 3/A Initial statement of beneficial ownership of securities
  7. 3/A Initial statement of beneficial ownership of securities
  8. 3/A Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 19 ownership filings

Prospectus 22

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  5. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  6. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  7. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  10. 424B4 Prospectus filed pursuant to Rule 424(b)(4)

All 22 prospectus filings

Other 331

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. EFFECT Notice of Effectiveness
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. F-1/A Registration statement for securities of certain foreign private issuers
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 331 other filings